Skip to content

Efficacy of FloSeal in endonasal endoscopic approach

Efficacy of FloSeal in endonasal endoscopic approach - Efficacy of FloSeal in endonasal endoscopic approach

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000038429
Enrollment
200
Registered
2019-10-29
Start date
2019-10-29
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cases who are treated via endonasal endoscopic approach at department of neurosurgery

Interventions

After treatment, we would apply FloSeal at the point of bleeding which was difficult to stop with other methods.

Sponsors

Keio University School of Medicine Department of Neurosurgery
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients will undergo endonasal endoscopic surgery, who is thought to be used FloSeal.

Exclusion criteria

Exclusion criteria: Who has allergy to bovine protein. Who has infection at the surgical field. The tumor is in the eye ball Who has coagulopathy Pregnant patient Who is diagnosed with Hypofibrinogenaemia Who the surgeons thought that it is not appropriate to use FloSeal.

Design outcomes

Primary

MeasureTime frame
Efficacy of FloSeal to stop bleeding The bleeding would be classified in 4 grades. (1.Mild 2. Moderate 3. Sever 4. Life-threatening) Succeed of hemostasis or not would be evaluated after applying FloSeal.

Secondary

MeasureTime frame
all the events occur during hospital stay after surgery.(maximum of 14 days) imaging lab data operative complications data of operation

Countries

Japan

Contacts

Public ContactMasahiro Toda

Keio University School of Medicine Department of Neurosurgery

todam@keio.jp03-5363-3808

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026